Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900749622> ?p ?o ?g. }
- W2900749622 endingPage "245" @default.
- W2900749622 startingPage "245" @default.
- W2900749622 abstract "An amphiphilic derivative of chitosan containing quaternary ammonium and myristoyl groups, herein named as ammonium myristoyl chitosan (DMCat), was synthesized by reacting glycidyltrimethylammonium chloride (GTMAC) and myristoyl chitosan (DMCh). The success of the modification was confirmed using Fourier-transform infrared spectroscopy (FTIR) and 1H nuclear magnetic resonance (NMR) spectroscopy. The average degrees of alkylation and quaternization ( D Q ¯ ) were determined by using 1H NMR and conductometric titration. The zeta potential of the micelles was higher than 28 mV while its average size and encapsulation efficiency ranged from 280 nm to 375 nm and 68% to 100%, respectively. The in vitro cytotoxicity of the unloaded and curcumin (CUR)-loaded micelles was tested against Caco-2 and HT29-MTX intestinal epithelial cell lines. The results showed no cytotoxic effect from loaded and unloaded micelles as compared to free CUR. In the permeability test, it was observed that both types of micelles, i.e., DMCh and DMCat, improved CUR permeability. Additionally, higher permeability was verified for both systems in Caco-2/HT29-MTX:Raji B because of the mucoadhesive character of chitosan and its ability to open tight junctions. The results indicated that DMCat micelles, due to the physico-chemical, improved characteristics may be a promising carrier to encapsulate CUR aiming cancer therapy." @default.
- W2900749622 created "2018-11-29" @default.
- W2900749622 creator A5002076093 @default.
- W2900749622 creator A5021189467 @default.
- W2900749622 creator A5039055502 @default.
- W2900749622 creator A5041458969 @default.
- W2900749622 creator A5055022776 @default.
- W2900749622 creator A5056972040 @default.
- W2900749622 creator A5088871980 @default.
- W2900749622 date "2018-11-20" @default.
- W2900749622 modified "2023-10-03" @default.
- W2900749622 title "N-(2-Hydroxy)-propyl-3-trimethylammonium, O-Mysristoyl Chitosan Enhances the Solubility and Intestinal Permeability of Anticancer Curcumin" @default.
- W2900749622 cites W1499008717 @default.
- W2900749622 cites W1569904453 @default.
- W2900749622 cites W1953531402 @default.
- W2900749622 cites W1968436748 @default.
- W2900749622 cites W1968906109 @default.
- W2900749622 cites W1976194786 @default.
- W2900749622 cites W1980763936 @default.
- W2900749622 cites W1988840190 @default.
- W2900749622 cites W1989268341 @default.
- W2900749622 cites W1990936095 @default.
- W2900749622 cites W1992287346 @default.
- W2900749622 cites W1994986226 @default.
- W2900749622 cites W1996312920 @default.
- W2900749622 cites W1997308573 @default.
- W2900749622 cites W1999968637 @default.
- W2900749622 cites W2001286327 @default.
- W2900749622 cites W2003103971 @default.
- W2900749622 cites W2003329070 @default.
- W2900749622 cites W2003768250 @default.
- W2900749622 cites W2004829858 @default.
- W2900749622 cites W2005204750 @default.
- W2900749622 cites W2006184155 @default.
- W2900749622 cites W2007262689 @default.
- W2900749622 cites W2007514493 @default.
- W2900749622 cites W2007878226 @default.
- W2900749622 cites W2017849557 @default.
- W2900749622 cites W2027550597 @default.
- W2900749622 cites W2029677759 @default.
- W2900749622 cites W2034471151 @default.
- W2900749622 cites W2038241878 @default.
- W2900749622 cites W2042118044 @default.
- W2900749622 cites W2044265633 @default.
- W2900749622 cites W2045730382 @default.
- W2900749622 cites W2046666495 @default.
- W2900749622 cites W2047431940 @default.
- W2900749622 cites W2051148659 @default.
- W2900749622 cites W2051820513 @default.
- W2900749622 cites W2056501647 @default.
- W2900749622 cites W2057640454 @default.
- W2900749622 cites W2059048390 @default.
- W2900749622 cites W2062039051 @default.
- W2900749622 cites W2068809055 @default.
- W2900749622 cites W2078481265 @default.
- W2900749622 cites W2087240044 @default.
- W2900749622 cites W2087795760 @default.
- W2900749622 cites W2090243647 @default.
- W2900749622 cites W2095358583 @default.
- W2900749622 cites W2139729210 @default.
- W2900749622 cites W2153957030 @default.
- W2900749622 cites W2160856601 @default.
- W2900749622 cites W2182990393 @default.
- W2900749622 cites W2184188263 @default.
- W2900749622 cites W2238183173 @default.
- W2900749622 cites W2252831137 @default.
- W2900749622 cites W2276169268 @default.
- W2900749622 cites W2312702537 @default.
- W2900749622 cites W2336729514 @default.
- W2900749622 cites W2344782712 @default.
- W2900749622 cites W2578491581 @default.
- W2900749622 cites W2579340176 @default.
- W2900749622 cites W2582664802 @default.
- W2900749622 cites W2583107517 @default.
- W2900749622 cites W2621511938 @default.
- W2900749622 cites W2624749758 @default.
- W2900749622 cites W2753627115 @default.
- W2900749622 cites W2771491442 @default.
- W2900749622 cites W2790446723 @default.
- W2900749622 cites W2792258330 @default.
- W2900749622 cites W2887607186 @default.
- W2900749622 cites W3103982839 @default.
- W2900749622 doi "https://doi.org/10.3390/pharmaceutics10040245" @default.
- W2900749622 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6320830" @default.
- W2900749622 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30463361" @default.
- W2900749622 hasPublicationYear "2018" @default.
- W2900749622 type Work @default.
- W2900749622 sameAs 2900749622 @default.
- W2900749622 citedByCount "18" @default.
- W2900749622 countsByYear W29007496222019 @default.
- W2900749622 countsByYear W29007496222020 @default.
- W2900749622 countsByYear W29007496222021 @default.
- W2900749622 countsByYear W29007496222022 @default.
- W2900749622 countsByYear W29007496222023 @default.
- W2900749622 crossrefType "journal-article" @default.
- W2900749622 hasAuthorship W2900749622A5002076093 @default.
- W2900749622 hasAuthorship W2900749622A5021189467 @default.
- W2900749622 hasAuthorship W2900749622A5039055502 @default.